Pharmafile Logo

Kraeber (UK) Ltd

The family owned business, Kraeber & Co GmbH, is an independent, technology based enterprise which was founded on the 1st January 1980 in Hamburg. Hanseatic tradition together with courageous entrepreneurship characterize our company. We are committed to open and global competition which we stand up with our service capabilities. Our emphasis is the development, production, marketing and sales of active pharmaceutical ingredients (APIs) of the highest purity. Kraeber has evolved into a niche marketer and supplier. By continously innovating productions, we became the quality market leader in Europe and in other parts of the world for many of our products.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

16 The Street, Saxon Street, Newmarket, Suffolk, CB8 9RU, United Kingdom
+44 (0)1638 731 297

 Latest Content from PMHub 

Patient Recruitment & Retention Webinar for Influenza Studies

Press Releases | August 12, 2024 | Innovative Trials

Join the upcoming webinar which will discuss key patient recruitment & retention challenges and solutions for upcoming influenza studies.

Clarity in clinical trials

Discover how transparent, empathetic communication and health literacy principles can empower patients and enhance engagement in clinical trials, transforming participants into active partners in their healthcare journey.

Enhancing Continuity with Online Meetings – Perks of Virtual Medical Education

Explore the power of online meetings for superior continuity in our latest video from the "Perks of Virtual Medical Education" series. Learn how shorter, more frequent virtual touchpoints allow for...

Mtech Access host transforming healthcare symposium

Press Releases | August 7, 2024 | Petauri Evidence

• Mtech Access are once again hosting a symposium looking at transforming the healthcare landscape in the UK and how to foster NHS–industry collaboration • Guest speakers from across the...

Caring for patients’ mental health in clinical trials

We look at why ensuring continuous mental health support for patients in clinical trials is essential to enhance their overall well-being and trial engagement.

The value of medical education in driving commercial success

Onyx Health's Sarah Seilly discusses how innovative, data-driven approaches to medical education and strategic collaborations with HCPs can drive engagement and ensure commercial success in an evolving healthcare industry.

[Free Whitepaper] 6 reasons why direct patient support is a ‘must have’ for your clinical trials

This white paper explores the importance of patient-first services and why direct patient support is crucial for the success of sponsors’ clinical trials. Download it for FREE 👉🏽  https://innovativetrials.com/six-reasons-why-direct-patient-support-is-a-must-have-for-your-clinical-trials/ 

Assessing opportunities for manufacturers to communicate the value of therapies to oncology clinical pathway (OCP) developers

Based on insights from 15 U.S. payers and providers, this white paper explores how manufacturers can effectively engage oncology clinical pathway (OCP) developers.

Leading the Way at ESC 2024

Anticipation is building at Medscape Education as the team prepares for the ESC 2024 Congress. We are excited to announce a significant presence during the congress including a booth (#H500)...

Driving equitable healthcare: The role of DE&I in clinical trials

Diversity, equity and inclusion (DE&I) is becoming a bigger topic of conversation and meaningful action within clinical trials. And for good reason, too. Find out why we embrace this and...